Assignee
PHARMEXA AS
DK·8 granted patents·6 pending applications·176 citations·filing 1998–2008
Top patents by PatentIndex Score
14 records- 0191US7135181B2Method for down-regulation of amyloidPHARMEXA AS·Filed 2001·Granted Nov 14, 2006·44 cites·24 claims
- 0286US7097837B2Synthetic vaccine agentsPHARMEXA AS·Filed 2002·Granted Aug 29, 2006·38 cites·23 claims
- 0385US7070784B1Method for down-regulating GDF-8 activity using immunogenic GDF-8 analoguesPHARMEXA AS·Filed 2000·Granted Jul 4, 2006·29 cites·10 claims
- 0481US7005498B1Methods for therapeutic vaccinationPHARMEXA AS·Filed 1999·Granted Feb 28, 2006·50 cites·5 claims
- 0573US7056512B1Method for down-regulating GDF-8 activityPHARMEXA AS·Filed 2000·Granted Jun 6, 2006·9 cites·28 claims
- 0664US2007041945A1Novel method for down-regulation of amyloidPHARMEXA AS·Filed 2006·Application pending·0 cites
- 0760US7285273B1Method for down-regulating IL5 activityPHARMEXA AS·Filed 2000·Granted Oct 23, 2007·2 cites·17 claims
- 0860US2009092579A1Novel method for down-regulation of amyloidPHARMEXA AS·Filed 2008·Application pending·0 cites
- 0952US2003082514A1Method for identification of biologically active peptides and nucleic acidsPHARMEXA AS·Filed 2002·Application pending·0 cites
- 1051US2008253993A1Immunogenic Egfr Peptides Comprising Foreign T Cell Stimulating EpitopePHARMEXA AS·Filed 2006·Application pending·0 cites
- 1149US2007184023A1Method for down-regulation of vegfPHARMEXA AS·Filed 2004·Application pending·0 cites
- 1241US6746669B1Method for down-regulating IL5 activityPHARMEXA AS·Filed 2000·Granted Jun 8, 2004·0 cites·34 claims
- 1341US2002172673A1Method for down-regulating IgEPHARMEXA AS·Filed 2001·Application pending·0 cites
- 1437US7118750B1Modified TNF-alpha molecules, DNA encoding such and vaccines comprising such modified TNF-alpha and DNAPHARMEXA AS·Filed 1998·Granted Oct 10, 2006·4 cites·6 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →